(GILD) Gilead Sciences Inc. – Momentum – Zacks Rank Buy

March 2nd, 2009

Gilead Sciences Inc. (GILD) continues to grow its earnings in a tough market on the strength of its HIV drug franchise. Gilead’s fourth-quarter results, reported on Jan 29, were once again of expectations.

Revenue was up 30% from last year to $1.43 billion. Earnings came in at 60 cents per share, 5 cents ahead of the consensus estimate. This was Gilead’s second consecutive earnings surprise.

Estimates Tick Higher

After the solid quarter, analysts went ahead and lifted their earnings projections. The current-year estimate is up 11 cents to $2.51 per share. The next-year estimate is bullish, pegged at $2.86, a 14% earnings growth projection.

The Chart

In spite of Gilead’s great quarter, market pressure has weighed on the company’s share price after encountering some short-term resistance just above the $53 mark. Take a look below.

Zacks Investment Research
View original at: Zacks.com News Feed

More on this topic (What's this?)
Gilead tops Astellas offer for CV Therapeutics (Fusion Investing and Analysis, 3/12/09)
Gilead Sciences, A Proven Track Record (Bullish Bankers, 1/31/09)
A Prescription for an Ailing Portfolio (Jutia Group, 2/22/09)
Weekly Stock Pick (Invest2Success, 12/29/08)
Read more on Gilead Sciences at Wikinvest

Related Posts:

  1. (APSG) Applied Signal Technology, Inc. – Momentum – Zacks Rank BuyApplied Signal Technology, Inc. (APSG) is rallying in response to the company’s excellent first-quarter results....
  2. (LANC) Lancaster Colony Corp. – Momentum – Zacks Rank BuyLancaster Colony Corp. (LANC) reported strong second-quarter results in late January and the company’s share...
  3. Cubic Corp. – Momentum – Zacks Rank BuyCubic Corp. (CUB) has rallied back to its 52-week high after reporting impressive first-quarter results...
  4. (IMA) Inverness Medical Technology Inc. – Momentum – Zacks Rank BuyInverness Medical Technology Inc. (IMA) just reported excellent fourth-quarter results and its share price continues...
  5. (STE) Steris Corporation – Growth And Income – Zacks Rank BuySteris Corporation (STE) has produced impressive surprises on earnings, topping analysts’ EPS estimates by an...
  6. (GILD) Gilead Sciences – estimates have continued to tick higher over the last few monthsGilead Sciences, Inc.’s (GILD) share price continues to head north in response to higher estimates...


Search Posts by Tag: | | Biotechnology | Healthcare

RSS Feeds by Tag: GILD | Gilead Sciences Incorporated | Biotechnology | Healthcare |

Other Posts by: | RSS Feed for this author